Your session is about to expire
← Back to Search
BION-1301 for Healthy Subjects
Study Summary
This trial is testing a new drug to see if it is safe and well tolerated in healthy Japanese subjects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Is enrollment still open for this research project?
"As per information hosted on clinicaltrials.gov, this medical study is still open to new participants, having been first posted on July 19th 2022 and most recently updated August 17th 2022."
How many participants are participating in this trial at its maximum capacity?
"Affirmative. Sources on clinicaltrials.gov demonstrate that this experiment, which was first published on July 19th 2022, is actively enrolling patients. About 36 participants are needed from a single medical site to complete the trial."
To what extent is BION-1301 hazardous to those receiving it?
"Due to the limited clinical research data available, BION-1301's safety profile has been rated a 1 on our scale of 1 to 3. This is in keeping with it being an early phase one trial."
Is the age eligibility for this research limited to those over 45 years old?
"The primary eligibility criteria for this clinical trial states that the patient must be between 20 and 60 years old. For those younger than 18, there are 50 studies available while 372 exist for individuals aged 65 or older."
What criteria must a potential participant meet to join this experiment?
"This clinical trial is admitting 36 individuals, aged between 20 and 60 years old with a healthy medical history. To qualify for the study, participants must also fulfill additional requirements such as having negative pregnancy or sperm donation tests (depending on gender), BMI of 18-30 kg/m^2, weight over 47kgs and first generation Japanese origin (confirmed at screening). Furthermore, to maintain eligibility female subjects of childbearing potential need to use highly effective contraceptive methods during their participation in the trial while male counterparts will have to follow the same guidelines but not donate sperm."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger